UNCY DEADLINE: SueWallSt Reminds Unicycive Therapeutics, Inc. Investors of Upcoming Securities Class Action Deadline
A securities class action alleges Unicycive Therapeutics told shareholders its oxylanthanum carbonate application was on track without ever inspecting its third-party manufacturer's facility for cGMP compliance. UNCY purchasers who lost $3.01 per share have specific rights under the federal securities laws. A securities class action alleges Unicycive Therapeutics told shareholders its oxylanthanum carbonate application was on track without ever inspecting its third-party manufacturer's facility for cGMP compliance. UNCY purchasers who lost $3.01 per share have specific rights under the federal securities laws.